Stock listing

Frankfurt:AP82 Aptevo Therapeutics Inc. Aktie

German listing (Frankfurt) of Aptevo Therapeutics Inc. · home listing NASDAQ:APVO

Follow Aptevo Therapeutics Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:APVO

$1.60 USD -0.02 (-1.2%)

Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:APVO

Since Jul 6, 2026 -64.2% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
$1.57 – $1.66 USDOct 19, 2026
Volume
8,188 sharesOct 19, 2026
Market value
$2.90M USDAt the close on Oct 19, 2026 · price × 1.81M shares outstanding
Aptevo Therapeutics Inc. logo
Ticker
Frankfurt:AP82
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All Aptevo Therapeutics Inc. news

Financings

  • Common stock on exercise of existing warrants

    Aug 13, 2026

    Closed: US$4.03 a share · Warrants at US$4.03 for 60 months · Roth Capital Partners, LLC

    Dealers: Roth Capital Partners, LLC (lead)

    Use of proceeds: Working capital

    Announced Aug 12, 2026 · Closed Aug 13, 2026

  • Private placement of unregistered shares of common stock (or pre-funded warrants) with common warrants

    Aug 13, 2026

    Closed: US$4.03 a share · Warrants at US$4.03 for 60 months · Roth Capital Partners, LLC

    Dealers: Roth Capital Partners, LLC (lead)

    Use of proceeds: Working capital

    Announced Aug 12, 2026 · Closed Aug 13, 2026

Read by 6ix AI from the company's releases

Decks

Aptevo Therapeutics Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
18 in the last 12 months · 95 in all · newest Oct 14, 2026 · oldest 2019
Decks
10 decks · latest Mar 20, 2025

Where Aptevo Therapeutics Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:APVO · Home listingNASDAQUnited StatesUSD
BOATS:APVOBOATSUnited StatesUSD
gettex:AP82gettexGermanyEUR
Frankfurt:AP82 · This pageFrankfurtGermanyEUR
Munich:AP82MunichGermanyEUR

Log in to ask 6ix AI your own questions about Aptevo Therapeutics Inc.